4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-000558
CVP, TAVR sold 1,019 shares at $85.70 ($87,332)
- CVP, TAVR acquired 1,019 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lippis Daniel J. · CVP, TAVR
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,019 | $59.26 | $60,383 | 23,020.91 | D |
| 2026-01-09 | Sale : show line 2 in the form 10b5-1 | −1,019 | $85.70 | $87,332 | 22,001.91 | D |
| Open-market sales · 1,019 sh · avg $85.70 · $87,332 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-09 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −1,019 | 4,076 | D |
Loading xslF345X05/doc4.xml…